{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-025001","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2021-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.811026+00:00","generated_at":"2026-06-28T21:45:21.785509+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nephros prelim Q3 2021 net revenue ~$2.6M (+24% YoY); YTD record $7.6M","bullets":["Preliminary net revenue ~$2.6M for Q3 2021, up 24% YoY.","Year-to-date revenue ~$7.6M, highest in company history (+22% vs 2020).","Third consecutive quarter of ~25% average YoY growth.","Pathogen Detection Systems segment contributed nearly $60K in Q3 revenue.","Cash ~$7.3M at quarter end; full results expected Nov 4, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-025001","json":"https://secwatch.observer/filing/0001493152-21-025001.json","markdown":"https://secwatch.observer/filing/0001493152-21-025001.md","text":"https://secwatch.observer/filing/0001493152-21-025001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/0001493152-21-025001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221025001/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T21:45:21.785509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}